Lead Biostatistician
Thermo Fisher Scientific- Full Time
- Junior (1 to 2 years)
Candidates should possess a Master’s degree in Biostatistics or a related field, with a strong foundation in statistics and clinical methodologies, combining classical techniques with cutting-edge innovations. They should thrive in fast-paced settings, handle competing priorities with ease, and be results-oriented and collaborative.
The Manager, Biostatistics will support statistical strategy for assigned drug programs, including input to clinical development plans, clinical study concepts and protocols design, SAPs, clinical study reports, regulatory documentation and associated publications. They will also be accountable for oversight of the production of biostatistics deliverables (TFLs, including planned, post-hoc, and/or exploratory analyses) as performed by external resources, and provide statistical strategy support and input in protocols, CSRs, and scientific presentations and manuscripts.
Develops therapies for autoimmune diseases
Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.